Health Minister JP Nadda Unveiled Medical Vaccination Plan for Haj Pilgrims

Sharing is caring!

Union Health Minister J P Nadda has said all arrangements will be made for providing vaccines to Haj pilgrims, following reports of paucity of meningitis vaccines in the country as the only firm manufacturing it was asked to stop production last year after contamination was detected in its oral polio vaccines.

The minister reviewed the availability of vaccines with the health secretary and senior officials on Monday.

“I assure that all arrangements will be made for providing vaccines to the Haj pilgrims,” Nadda said a tweet.

According to sources in the Health Ministry, the only firm, which manufactured the vaccines and provided it to the government, was asked to stop production of all human vaccines in September last year after type-2 polio virus contamination was detected in oral polio vaccines.

Following the ban on the Ghaziabad-based pharmaceutical company, Biomed Pvt. Ltd., the ministry is now looking for options to arrange the vaccines in time for vaccinating the pilgrims, the sources said.

Around 1.27 lakh people are expected to go for the annual Haj pilgrimage in July this year for which the ministry will have to arrange for at least 1.9 lakh doses.

Extra vaccines are kept as some are rendered ineffective in the process of delivery to the states.

The Health Ministry is already in talks with two firms which import the vaccines, the sources said.

Those going to Saudi Arabia for the purpose of ‘Umrah’ are required to submit a certificate of vaccination with the quadrivalent (ACYW 135) vaccine against meningitis, proving the vaccine was administered no more than three years ago and no less than 10 days before arrival in the country.

Biomed Pvt. Ltd. was a licensed indigenous manufacturer for Meningococcal Polysaccharide vaccine while two Mumbai-based firms M/s Sanofi Pastuer India Pvt. Lt. and M/s GlaxoSmithkline Pharmaceuticals Ltd. are importers for quadrivalent Meningcoccal Meningitis Conjugate Vaccine in the country.

“Earlier with Biomed Pvt. Ltd. providing the vaccines, government spent Rs 250 for each vaccine but now if they have to buy from companies which import the vaccines, they may have to shell out around Rs 1,500 per dose. The Health Ministry is already in talks with the two firms which import the vaccines,” the sources said.

Biomed Pvt. Ltd. was directed to stop the manufacture, sale and distribution of all human vaccines, including the Quadrivalent Meningococcal Meningitis vaccine, after type-2 polio virus was found in the sewage and stool samples in Maharashtra, Telangana and Uttar Pradesh in September last year.

The polio drops were sent for testing which confirmed that some of them were contaminated with type-2 virus, a strain believed to have been eradicated in 2016.

The managing director of Biomed Pvt. Ltd., which was supplying polio vaccines for only government-run immunisation programmes, was arrested after the central drug regulator filed a complaint and an FIR was registered.

The destruction of traces of type-2 polio virus was ordered by the central drug regulator to all manufacturers in 2016.

SMEStreet Desk

SMEStreet is fast growing platform dedicated to entrepreneurs from small and medium sized businesses (SMEs). Committed to facilitate Knowledge & Networking for Business Growth, SMEStreet offers value added content which shows the actual voice of Indian MSMEs.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button
%d bloggers like this: